CNBX Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CNBX research report →
About the company
CNBX Pharmaceuticals Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing cannabinoid-based treatments and therapies for various cancers. Its flagship product candidate, RCC-33, is an oral capsule formulation of cannabinoids specifically engineered for treating colorectal cancer.
- CEO
- Eyal Barad
- IPO
- 2007
- Employees
- 1
- HQ
- Bethesda, MD, US
Price Chart
- Market Cap
- $13.88K
- P/E
- 0.15
- P/S
- 0.00
- P/B
- -0.07
- EV/EBITDA
- -0.29
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 18.01%
- ROIC
- 16.91%
- Revenue
- $0 · -100.00%
- Net Income
- $-313,976 · 54.82%
- EPS
- $-0.00 · 84.78%
- Op Income
- $-271,691
- FCF YoY
- 30.21%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.69
- Avg Volume
- 39.94M
Get TickerSpark's AI analysis on CNBX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 25, 14 | Cannabics Inc. | sell | 18,239,594 |
| Jun 23, 14 | Cannabics Inc. | sell | 14,525,000 |
| May 8, 14 | Cannabics Inc. | sell | 20,500,000 |
| May 8, 14 | MILLS THOMAS E | sell | 20,500,000 |
| Apr 25, 14 | MILLS THOMAS E | sell | 20,500,000 |
| Oct 28, 13 | MILLS THOMAS E | buy | 20,000,000 |
| Oct 28, 13 | MILLS THOMAS E | buy | 20,000,000 |
| Jun 28, 13 | MILLS THOMAS E | other | 20,000,000 |
| Jun 24, 13 | MILLS THOMAS E | buy | 20,000,000 |
| Nov 8, 11 | North American Mining Corp | other | 31,000,000 |
Our CNBX coverage
Recent articles, reports, and earnings notes.
No research on CNBX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CNBX report →Similar companies
Peers in the same neighborhood.